Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.
's stock had its "hold" rating reiterated by investment analysts at Jefferies Group in a report issued on Monday, Market Beat Ratings reports. They currently have a $97.00 price target on the biopharmaceutical company's stock, down from their prior price target of $100.00.
from Biotech News
0 Comments